Ticker
TSHACompany Name
TAYSHA GENE THERAPIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Book Value per Share | Shareholders Equity | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ 0.83 | $ 248.73M | 1 | 297.99M |
3/31/2025 | $ 0.2 | $ 55.06M | 1 | 269.31M |
12/31/2024 | $ 0.29 | $ 71.53M | 1 | 250.13M |
9/30/2024 | $ 0.33 | $ 88.8M | 1 | 267.82M |
6/30/2024 | $ 0.47 | $ 108.87M | 1 | 232.82M |
3/31/2024 | $ 0.23 | $ 53.85M | 1 | 231.25M |
12/31/2023 | $ 0.65 | $ 74.94M | 1 | 116.12M |
9/30/2023 | $ -0.39 | $ -49.11M | 1 | 125.7M |
6/30/2023 | $ -0.58 | $ -37.11M | 1 | 64.24M |
3/31/2023 | $ -0.24 | $ -14.95M | 1 | 63.26M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Equity / (Shares WA * Share Factor)
(=) BVPS
BVPS for TAYSHA GENE THERAPIES INC is calculated as follows: Equity [ $ 267.64M ] / (Shares WA [ 11.73M ] * Share Factor [ 1 ])
(=) BVPS [ $ 22.81 ]
Minimum
Jun 30, 2023
Maximum
Sep 30, 2020
Average
Median
filtered constituents | 4K |
---|---|
min | $ -30.1 |
max | $ 46.85 |
average | $ 10.28 |
median | $ 6.03 |
std | $ 12.44 |